Background/Aims: The antiretroviral protease inhibitor saquinavir is used for the treatment of HIV infections. Effects of saquinavir include induction of apoptosis, the suicidal death of nucleated cells. Saquinavir treatment may further lead to anemia. In theory, anemia could result from accelerated erythrocyte loss by enhanced suicidal erythrocyte death or eryptosis, which is characterized by cell shrinkage and cell membrane scrambling with phosphatidylserine translocation to the erythrocyte surface. Stimulators of eryptosis include Ca 2+ entry with increase of cytosolic Ca 2+ activity ([Ca 2+ ] i ), oxidative stress with increase of reactive oxygen species (ROS) and ceramide. The present study explored, whether and how saquinavir induces eryptosis. Methods: To this end, flow cytometry was employed to estimate erythrocyte volume from forward scatter, phosphatidylserine exposure at the cell surface from annexin-V-binding, [Ca 2+ ] i from Fluo3-fluorescence, ROS abundance from DCFDA fluorescence and ceramide abundance utilizing specific antibodies. Results: A 48 hours exposure of human erythrocytes to saquinavir significantly decreased forward scatter (≥ 5 µg/ml), significantly increased the percentage of annexin-V-binding cells (≥ 10 µg/ml), significantly increased Fluo3-fluorescence (15 µg/ml), significantly increased DCFDA fluorescence (15 µg/ml), but did not significantly modify ceramide abundance. The effect of saquinavir on annexin-V-binding was significantly blunted, but not abolished by removal of extracellular Ca 2+ . Conclusions: Saquinavir triggers cell shrinkage and phospholipid scrambling of the erythrocyte cell membrane, an effect in part due to stimulation of ROS formation and Ca 2+ entry.
Introduction
Saquinavir, an antiretroviral protease inhibitor [1, 2] , is utilized for the treatment of HIV infections [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] . Saquinavir and its nitric oxide-derivative have been shown to trigger or foster apoptosis [22] [23] [24] [25] [26] [27] [28] [29] [30] , an effect paralleled by inhibition of AKT-phosphorylation [22] , downregulation of NF-κB [24, 28, 29] , proteotoxic stress [22] , endoplasmic reticulum stress [25] , autophagy [25] and mitochondrial depolarization [31] .
Side effects of saquinavir include anemia [32] . In theory, anemia could result from stimulation of eryptosis [33] , the suicidal death of erythrocytes characterized by cell shrinkage [34] and cell membrane scrambling with phosphatidylserine translocation to the cell surface [33] . Signaling stimulating eryptosis includes opening of Ca 2+ permeable unselective cation channels with subsequent Ca 2+ entry and increase of cytosolic Ca 2+ activity ([Ca 2+ ] i ) [33] , oxidative stress [33] , ceramide [33] , energy depletion [33] , caspases, casein kinase 1α, Janus-activated kinase JAK3, protein kinase C and p38 kinase [33] . Signaling inhibiting eryptosis includes AMP activated kinase AMPK, cGMP-dependent protein kinase, PAK2 kinase, and sorafenib/sunitinib sensitive kinases [33] . Eryptosis is stimulated by a wide variety of xenobiotics [33, ].
The present study tested a putative effect of saquinavir on eryptosis. To this end, human erythrocytes from healthy volunteers were treated with saquinavir and phosphatidylserine surface abundance, cell volume as well as [Ca 2+ ] i and ROS formation determined by flow cytometry.
Materials and Methods

Erythrocytes, solutions and chemicals
Fresh Li-Heparin-anticoagulated blood samples were kindly provided by the blood bank of the University of Tübingen. The study is approved by the ethics committee of the University of Tübingen (184/2003 V). The blood was centrifuged at 120 x g for 20 min at 21°C and the platelets and leukocytes-containing supernatant was disposed. Erythrocytes were incubated in vitro at a hematocrit of 0.4% in Ringer solution containing (in mM) 125 NaCl, 5 KCl, 1 MgSO 4 , 32 N-2-hydroxyethylpiperazine-N-2-ethanesulfonic acid (HEPES; pH 7.4), 5 glucose, 1 CaCl 2 , at 37°C for 48 hours. Where indicated, erythrocytes were exposed to saquinavir (Sigma Aldrich, Hamburg, Germany) at the indicated concentrations.
Annexin-V-binding and forward scatter
After incubation under the respective experimental condition, a 150 µl cell suspension was washed in Ringer solution containing 5 mM CaCl 2 and then stained with Annexin-V-FITC (1:200 dilution; ImmunoTools, Friesoythe, Germany) in this solution at 37°C for 15 min under protection from light. The annexin V abundance at the erythrocyte surface was subsequently determined on a FACS Calibur (BD, Heidelberg, Germany). Annexin-V-binding was measured with an excitation wavelength of 488 nm and an emission wavelength of 530 nm. A marker (M1) was placed to set an arbitrary threshold between annexin-V-binding cells and control cells. The same threshold was used for untreated and saquinavir treated erythrocytes. A dot plot of forward scatter (FSC) vs. side scatter (SSC) was set to linear scale for both parameters. The threshold of forward scatter was set at the default value of "52". 
Intracellular Ca
Reactive oxidant species (ROS)
Oxidative stress was determined utilizing 2',7'-dichlorodihydrofluorescein diacetate (DCFDA). After incubation, a 150 µl suspension of erythrocytes was washed in Ringer solution and then stained with DCFDA (Sigma, Schnelldorf, Germany) in Ringer solution containing DCFDA at a final concentration of 10 µM. Erythrocytes were incubated at 37°C for 30 min in the dark and then washed two times in Ringer solution. The DCFDA-loaded erythrocytes were resuspended in 200 µl Ringer solution and ROS-dependent fluorescence intensity was measured at an excitation wavelength of 488 nm and an emission wavelength of 530 nm on a FACS Calibur (BD).
Results
The present study explored, whether exposure of human erythrocytes to saquinavir is followed by stimulation of suicidal erythrocyte death or eryptosis, which is characterized by cell shrinkage and cell membrane scrambling with phosphatidylserine translocation to the cell surface.
In order to estimate erythrocyte cell volume, forward scatter was determined utilizing flow cytometry. Measurements were made following a 48 hours incubation in Ringer solution without or with saquinavir (2.5 -15 µg/ml). As illustrated in Fig. 1 , saquinavir decreased erythrocyte forward scatter, an effect reaching statistical significance at 5 µg/ml saquinavir concentration.
Phosphatidylserine exposing erythrocytes were identified utilizing annexin-Vbinding, which was determined by flow cytometry. Again, the erythrocytes were analysed 
following incubation for 48 hours in Ringer solution without or with saquinavir (2.5 -15 µg/ml). As shown in Fig. 2 ] i ) was estimated from Fluo3 fluorescence. As illustrated in Fig. 3, a 48 hours exposure to saquinavir increased the Fluo3 fluorescence, an effect reaching statistical significance at 15 µg/ml saquinavir. In order to test whether the saquinavir-induced translocation of phosphatidylserine required entry of extracellular Ca . Thus, saquinavir-induced cell membrane scrambling was in large part but not exclusively due to entry of extracellular Ca 2+ .
Stimulators of Ca
2+ entry and eryptosis include oxidative stress. The abundance of reactive oxygen species (ROS) was thus quantified utilizing 2′,7′-dichlorodihydrofluorescein diacetate (DCFDA). As shown in Fig. 5 , a 48 hours exposure to saquinavir (15 µg/ml) significantly increased the DCFDA fluorescence, an observation pointing to induction of oxidative stress. As eryptosis is further stimulated by ceramide, the ceramide abundance was quantified utilizing specific antibodies. As a result, following a 48 hours incubation, the ceramide abundance was similar in the absence (15.2 ± 0.3, n = 11) and in the presence of saquinavir (14.3 ± 0.4, n = 11). Thus, saquinavir did not significantly modify the ceramide abundance. Waibel
Discussion
The present observations reveal a novel effect of saquinavir, i.e. the triggering of suicidal erythrocyte death or eryptosis. Exposure of human erythrocytes to saquinavir is followed by cell shrinkage and cell membrane scrambling with phosphatidylserine translocation to the erythrocyte surface.
The effect of saquinavir on eryptosis is apparently in large part due to Ca 2+ entry from the extracellular space with increase of cytosolic Ca 2+ activity ([Ca   2+ ] i ). An increase of [Ca 2+ ] i is known to stimulate cell membrane scrambling by activating an illdefined scramblase [33] . An increase of [Ca 2+ ] i is further followed by erythrocyte shrinkage due to activation of Ca 2+ sensitive K + channels, K + exit, cell membrane hyperpolarization, Cl -exit and thus cellular loss of KCl with water [34] .
The Ca 2+ entry from the extracellular space presumably results from activation of Ca 2+ permeable cation channels, which are known to be activated by oxidative stress [33] . According to DCFDA fluorescence, saquinavir treatment does increase the abundance of reactive oxygen species. Saquinavir induced eryptosis is presumably not the result of ceramide formation.
As phosphatidylserine exposing erythrocytes are engulfed by phagocytosing cells, stimulation of eryptosis leads to the rapid clearance of the affected erythrocytes [33] . The removal of eryptotic erythrocytes precedes and may thus prevent hemolysis of defective erythrocytes with release of hemoglobin, which may undergo filtration in renal glomeruli, precipitate in the acidic lumen of renal tubules, occlude nephrons and thus compromise renal function [60] . In malaria, eryptosis further initiates the clearance of Plasmodium infected erythrocytes. The pathogen activates Ca 2+ -permeable erythrocyte cation channels by imposing oxidative stress on the infected host cell [33, 61] . The clearance of eryptotic infected erythrocytes counteracts the development of parasitemia and thus favourably influences the clinical course of malaria. Presumably due to enhanced susceptibility to eryptosis, sickle-cell trait, beta-thalassemia-trait, Hb-C and G6PD-deficiency protect against a severe course of malaria [33, [62] [63] [64] . The enhanced eryptosis counteracts the increase of parasitemia and thus favourably influences the clinical course of malaria further in iron deficiency [65] and during treatment with lead [65] , chlorpromazine [66] or NO synthase inhibitors [66] . Possibly, saquinavir similarly enhances the susceptibility of Plasmodium infected erythrocytes to eryptosis.
In any case, the observed stimulation of eryptosis presumably contributes to the saquinavir induced anemia [32] , as the concentrations required to stimulate eryptosis are well in the range of concentrations encountered in vivo [22, 67] . Phosphatidylserine exposing erythrocytes further adhere to the vascular wall [68] , stimulate blood clotting and trigger thrombosis [69] [70] [71] , thus impairing microcirculation [69, [72] [73] [74] [75] [76] . Saquinavir sensitivity may be enhanced in clinical conditions with stimulated eryptosis, such as dehydration [48] , hyperphosphatemia [58] , chronic kidney disease (CKD) [40, [77] [78] [79] , hemolytic-uremic syndrome [80] , diabetes [81] , hepatic failure [82] , malignancy [33] , sepsis [83] , sicklecell disease [33] , beta-thalassemia [33] , Hb-C and G6PD-deficiency [33] , as well as Wilsons disease [84] .
In conclusion, saquinavir triggers eryptosis with cell shrinkage and cell membrane scrambling, an effect paralleled by and in part due to induction of oxidative stress and increase of cytosolic Ca 2+ activity. 
